The Global Interventional Cardiology Devices
Market is anticipated to reach around USD
25.2 billion by 2020. High incidence of heart related disorders can
directly impact product demand over the forecast period (2012 to 2020).
Valvuloplasty, angioplasty, and coronary thrombectomy are procedures that need
such devices. Key industry drivers are popularity of minimally invasive
surgeries and unhealthy lifestyles that trigger the onset of cardiovascular
anomalies. Also, rising cases of congenital heart diseases may positively
impact the overall market in the years to come. The use of novel devices and
new drug therapies in treating cardiovascular disorders has led to higher life
expectancy and better quality of life of patients. According to the World
Health Organization (WHO), number of deaths caused by cardiovascular disorders
is expected to be nearly 23.3 million by 2030.
Browse Details of Report @ https://www.hexaresearch.com/research-report/interventional-cardiology-devices-industry
The
worldwide Interventional Cardiology Devices Market is segmented on the basis of
products and regions. On the basis of products, the divisions are balloon
inflation devices, PTCA balloons, stents, PTCA guidewires, and interventional
cardiology catheters. With a market share exceeding 70%, interventional
cardiology catheters dominated the global industry in 2013. Application of
novel technologies that lower the risks of post-operative complications and
restenosis in angioplasty is a key factor that drives this segment. Different
types of stents are bio-absorbable, drug eluting, and metal. Bare metal stents
have helped in lowering the rates of restenosis by around 20 to 25 percent.
However,
owing to greater effectiveness, bio-absorbable & drug eluting stents are
increasingly being used in place of bare metal stents. The bio-absorbable
stents segment may register the highest growth rate in the forecast period.
This is attributed to increasing awareness about the benefits of such stents,
such as their ability to lower the possibility of restenosis. Catheters are a
rapidly growing product segment because these are utilized extensively in
minimally invasive medical procedures. Due to the high incidence of
cardiovascular disorders, demand for angioplasty catheters may surge in the
forthcoming years. This segment is propelled by technological advancements,
widespread patient awareness, and prevalence of structural & congenital
heart ailments.
Geographically,
the global interventional cardiology devices market is categorized into Europe,
North America, Asia Pacific, and Rest of the World. With shares surpassing 35%,
North America dominated the overall industry in 2013. Widespread awareness in
advanced economies and the presence of large pediatric & geriatric
populations are key regional drivers. According to the American Heart
Association, nearly 22% of the pediatric population belonging to the 6 to 17
years age group suffers from cardiovascular disorders. This owes to the
prevalence of obesity in the region. Asia Pacific can expand at the highest
CAGR over the forecast period because of popularity of minimally invasive
procedures that ensure quick recoveries and cause minimal trauma to patients.
Key
companies in the worldwide interventional cardiology devices industry are
Boston Scientific, Abbott Laboratories, Terumo Medical Corporation, B. Braun
Melsungen AG, and Cordis Corporation among others. In December 2016, Boston
Scientific launched the SYNERGY stent. This product has been approved by the US
FDA for use in the treatment of coronary artery disease. It is the first ever
stent that offers synchronized polymer & drug absorption. It enables
complete & rapid arterial healing and thus lowers the risks of
complications pertaining to long term polymer exposure.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry
About Us:
Hexa
Research is a market research and consulting organization, offering industry
reports, custom research and consulting services to a host of key industries across
the globe. We offer comprehensive business intelligence in the form of industry
reports which help our clients obtain clarity about their business environment
and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan
Shaw
Hexa
Research
Felton
Office Plaza
6265
Highway 9
Felton,
California 95018
United
States
Phone:
+1-800-489-3075
Email:
sales@hexaresearch.com
Website
- http://www.hexaresearch.com/
Visit Our
Blog - https://hexaresearchinc.wordpress.com/
No comments:
Post a Comment